Literature DB >> 23349036

Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.

Gun-Hwa Kim1, Edmond Changkyun Park, Sung-Ho Yun, Yeonhee Hong, Dong-Gyu Lee, Eun-Young Shin, Jongsun Jung, Young Hwan Kim, Kyung-Bok Lee, Ik-Soon Jang, Zee-Won Lee, Young-Ho Chung, Jong-Soon Choi, Chaejoon Cheong, Soohyun Kim, Seung Il Kim.   

Abstract

Type 2 diabetes mellitus (T2DM) is the most prevalent and serious metabolic disease affecting people worldwide. T2DM results from insulin resistance of the liver, muscle, and adipose tissue. In this study, we used proteomic and bioinformatic methodologies to identify novel hepatic membrane proteins that are related to the development of hepatic insulin resistance, steatosis, and T2DM. Using FT-ICR MS, we identified 95 significantly differentially expressed proteins in the membrane fraction of normal and T2DM db/db mouse liver. These proteins are primarily involved in energy metabolism pathways, molecular transport, and cellular signaling, and many of them have not previously been reported in diabetic studies. Bioinformatic analysis revealed that 16 proteins may be related to the regulation of insulin signaling in the liver. In addition, six proteins are associated with energy stress-induced, nine proteins with inflammatory stress-induced, and 14 proteins with endoplasmic reticulum stress-induced hepatic insulin resistance. Moreover, we identified 19 proteins that may regulate hepatic insulin resistance in a c-Jun amino-terminal kinase-dependent manner. In addition, three proteins, 14-3-3 protein beta (YWHAB), Slc2a4 (GLUT4), and Dlg4 (PSD-95), are discovered by comprehensive bioinformatic analysis, which have correlations with several proteins identified by proteomics approach. The newly identified proteins in T2DM should provide additional insight into the development and pathophysiology of hepatic steatosis and insulin resistance, and they may serve as useful diagnostic markers and/or therapeutic targets for these diseases.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349036     DOI: 10.1002/pmic.201200210

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  10 in total

1.  In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model.

Authors:  Melissa A Suter; Jun Ma; Patricia M Vuguin; Kirsten Hartil; Ariana Fiallo; R Alan Harris; Maureen J Charron; Kjersti M Aagaard
Journal:  Am J Obstet Gynecol       Date:  2014-05       Impact factor: 8.661

2.  Metabolomic Analysis of Serum and Tear Samples from Patients with Obesity and Type 2 Diabetes Mellitus.

Authors:  Erdenetsetseg Nokhoijav; Andrea Guba; Ajneesh Kumar; Balázs Kunkli; Gergő Kalló; Miklós Káplár; Sándor Somodi; Ildikó Garai; Adrienne Csutak; Noémi Tóth; Miklós Emri; József Tőzsér; Éva Csősz
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1(+/-)/Akt2(-/-) mice.

Authors:  Brian A Pedersen; Weiwen Wang; Jared F Taylor; Omar S Khattab; Yu-Han Chen; Robert A Edwards; Puya G Yazdi; Ping H Wang
Journal:  Metabolism       Date:  2015-09-12       Impact factor: 8.694

Review 4.  Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

Authors:  Joost Willebrords; Isabel Veloso Alves Pereira; Michaël Maes; Sara Crespo Yanguas; Isabelle Colle; Bert Van Den Bossche; Tereza Cristina Da Silva; Cláudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Alves; Bruno Cogliati; Mathieu Vinken
Journal:  Prog Lipid Res       Date:  2015-06-11       Impact factor: 16.195

5.  Dysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptake.

Authors:  Sumera Karim; Evaggelia Liaskou; Janine Fear; Abhilok Garg; Gary Reynolds; Lee Claridge; David H Adams; Philip N Newsome; Patricia F Lalor
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

6.  Steap4 attenuates high glucose and S100B-induced effects in mesangial cells.

Authors:  Chao-Tang Chuang; Jinn-Yuh Guh; Chi-Yu Lu; Yeng-Tseng Wang; Hung-Chun Chen; Lea-Yea Chuang
Journal:  J Cell Mol Med       Date:  2015-03-27       Impact factor: 5.310

7.  The Identification of Novel Protein-Protein Interactions in Liver that Affect Glucagon Receptor Activity.

Authors:  Junfeng Han; Ming Zhang; Sean Froese; Feihan F Dai; Mélanie Robitaille; Alpana Bhattacharjee; Xinyi Huang; Weiping Jia; Stéphane Angers; Michael B Wheeler; Li Wei
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

8.  Genome-wide association study for feed efficiency and growth traits in U.S. beef cattle.

Authors:  Christopher M Seabury; David L Oldeschulte; Mahdi Saatchi; Jonathan E Beever; Jared E Decker; Yvette A Halley; Eric K Bhattarai; Maral Molaei; Harvey C Freetly; Stephanie L Hansen; Helen Yampara-Iquise; Kristen A Johnson; Monty S Kerley; JaeWoo Kim; Daniel D Loy; Elisa Marques; Holly L Neibergs; Robert D Schnabel; Daniel W Shike; Matthew L Spangler; Robert L Weaber; Dorian J Garrick; Jeremy F Taylor
Journal:  BMC Genomics       Date:  2017-05-18       Impact factor: 3.969

9.  Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.

Authors:  Kerstin Lohr; Fiona Pachl; Amin Moghaddas Gholami; Kerstin E Geillinger; Hannelore Daniel; Bernhard Kuster; Martin Klingenspor
Journal:  Physiol Rep       Date:  2016-10

10.  Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes.

Authors:  Xiaofeng Ye; Tianshu Zeng; Wen Kong; Lu-Lu Chen
Journal:  J Immunol Res       Date:  2020-10-06       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.